Covid-19 roundup: Nor­mal life is in sight, but not with­out fur­ther vac­ci­na­tions — Bourla; For the 3rd time, EU ...

4 years ago
Coronavirus

Mer­ck, Pfiz­er end patent feud over pneu­mo­coc­cal vac­cines with roy­al­ty-cen­tered set­tle­ment

4 years ago
Pharma

The coro­n­avirus vac­cine that the world for­got could still help save it

4 years ago
Coronavirus
In Focus

DE­VEL­OP­ING News: Ac­celeron ne­go­ti­at­ing $11B buy­out; 11 promis­ing biotech star­tups; Changes ga­lore at No­var­tis; ...

4 years ago
Weekly

Days of heat­ed ru­mors cul­mi­nate in a re­port that Ac­celeron is in ad­vanced buy­out talks

4 years ago
Deals
R&D

New ARIA cas­es dog Bio­gen's Aduhelm launch in an­oth­er po­ten­tial blow to block­buster hopes — an­a­lyst

4 years ago
FDA+

Capri­cor's DMD clin­i­cal tri­al meets pri­ma­ry end­points; Delaware court rules against Take­da in Lupron feud

4 years ago
News Briefing

Trevor Bed­ford, Cigall Kadoch among this year's in­com­ing HH­MI in­ves­ti­ga­tors

4 years ago
People
Financing

Mi­cro­cap gene ther­a­py play­er says three chil­dren suf­fered se­ri­ous side ef­fects in PhI/II study

4 years ago
R&D
Cell/Gene Tx

Covid-19 roundup: SAB's an­ti­body treat­ments move to PhI­II; Af­ter long jour­ney, No­vavax sub­mits vac­cine to WHO for ...

4 years ago
Coronavirus

As­traZeneca and Mer­ck hope new da­ta can PRO­pel their PARP in­hibitor in­to first-line prostate can­cer

4 years ago
R&D

CDC di­rec­tor over­rules ad­vi­sors on boost­ers, rec­om­mend­ing third shots for at-risk work­ers

4 years ago
FDA+

With Mav­er­ick now in Takeda's hands, James Sci­bet­ta turns the page; Roivant CMO leaves in fa­vor of small IL-2 biotech

4 years ago
Peer Review

In step for­ward for re­ju­ve­na­tion field, re­searchers turn back the clock on mice hearts

4 years ago
Discovery

Till­man Gern­gross project out of Dart­mouth Col­lege ac­quired by Repli­gen

4 years ago
Deals
Manufacturing

Lon­za un­veils new ex­pan­sion plans at Swiss man­u­fac­tur­ing sites, cap­ping off a very busy pan­dem­ic

4 years ago
Manufacturing

Take­da breaks ground on ze­ro-emis­sion site in Asia; Boston Labs emerges from stealth with mo­bile cell, gene ther­a­py ...

4 years ago
Manufacturing

Catal­ent inks deal with Phath­om to make GI drug at re­cent­ly-ren­o­vat­ed Ken­tucky site

4 years ago
Outsourcing
Manufacturing

UNC re­searchers re­port a new way to charge CAR-T against sol­id tu­mors

4 years ago
Discovery
Cell/Gene Tx

HHS lines up No­var­tis, Lil­ly, As­traZeneca and 3 oth­er drug­mak­ers for fines due to drug dis­count vi­o­la­tions

4 years ago
Pharma

FDA's can­cer drug ad­vi­sors will re­view 2 more dan­gling ac­cel­er­at­ed ap­provals for mul­ti­ple myelo­ma, leukemia

4 years ago
FDA+

Fol­low­ing con­tro­ver­sial Aduhelm ap­proval, DC-based neu­rol­o­gy cen­ter bans Bio­gen rep­re­sen­ta­tives from its of­fices — ...

4 years ago
Pharma
FDA+

Re­call re­port: Pfiz­er pulls even more Chan­tix lots as ni­trosamine con­t­a­m­i­na­tion wor­ries grow

4 years ago
Manufacturing

Roche's Foun­da­tion Med­i­cine is get­ting a new 16-sto­ry home in Boston's Sea­port Dis­trict

4 years ago
Pharma
First page Previous page 645646647648649650651 Next page Last page
A service from the Financial Times